Session Type
Meeting
Search Results for infection
Abstract Number: M2
SHM Converge 2022
Case Presentation: A 44-year-old man with multiple myeloma and cardiac amyloidosis on chemotherapy, and atrial fibrillation on apixaban, presented with three days of worsening shortness of breath and edema. He was admitted to the emergency room observation unit for treatment of a mild heart failure exacerbation. He was noted on admission to have rapidly developed […]
Abstract Number: 101
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: TOUR™ is a multicenter study designed to characterize the real-world population characteristics and clinical outcomes associated with telavancin (TLV) use through retrospective medical chart review. Telavancin is a lipoglycopeptide antibacterial active against gram-positive pathogens, including methicillin-sensitive and -resistant Staphylococcus aureus (MSSA and MRSA). In the US, TLV is approved for hospital-acquired (HABP) and ventilator-associated […]
Abstract Number: 102
Hospital Medicine 2020, Virtual Competition
Background: Hospital at home (HaH) programs have shown efficacy as substitutes for high-cost, traditional hospitalization in patients who are primarily low-acuity and with a range of medical conditions, including community-acquired pneumonia (CAP) and urinary tract infection (UTI). However, wide-spread adoption is minimal as providers and patients are challenged to consider HaH at the time of […]
Abstract Number: 106
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Hospitalized patients placed on contact, droplet, or respiratory isolation due to a carrier state or infection with resistant or highly communicable organisms report higher rates of anxiety and loneliness and have fewer physician encounters, room entries, vital sign records, physician and nursing notes in the chart. For these reasons, it has been hypothesized that […]
Abstract Number: 114
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Procalcitonin (PCT) is a precursor peptide to calcitonin produced by the thyroid parafollicular cells, and the intestinal and lung neuroendocrine cells. PCT is a proinflammatoy marker specific to bacterial infections, and was initially used clinically to guide antibiotic therapy in lower respiratory tract infections. PCT has seen its role expanded to aid with initiation, […]
Abstract Number: 116
SHM Converge 2023
Background: Researchers across the globe have continued their effort in identifying important risk factors for severe COVID-19 infection. Patient demographics including age, race, gender, and certain chronic medical conditions including cardiovascular disease, diabetes, hypertension, and heart failure have been identified as the important risk factors for severity. To simply the risk stratification process, the CHA2DS2-VASc […]
Abstract Number: 118
Hospital Medicine 2020, Virtual Competition
Background: For peripherally compatible infusates planned for
Abstract Number: 118
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Guidelines for peripherally inserted central catheters (PICCs) recommend avoiding insertion if the anticipated use is 5 or fewer days. However, short-term PICC use is common in hospitals. We sought to identify patient-, provider- and device-characteristics associated with short-term PICC use. Methods: Between January 2014 and June 2016, trained abstractors at each of 51 Michigan […]
Abstract Number: 118
SHM Converge 2024
Background: Pneumocystis pneumonia (PCP) is a life-threatening opportunistic infection that leads to severe pneumonia in immunocompromised hosts. This results in respiratory failure and hypoxemia. Its reported survival rate ranges from 20% to 50%. Despite its seriousness, there is limited research on the occurrence of PCP in children, likely due to its infrequency. Current national data […]
Abstract Number: 119
SHM Converge 2024
Background: Hepatic artery pseudoaneurysm (HAP) is a rare entity, potentially life threatening and associated with high mortality. The aim of this study was to evaluate Mayo Clinic enterprise’s clinical experience with HAP occurrence, clinical features and outcome in the last 20 years, and to compare our results with what the literature. Methods: This retrospective analysis […]